{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T21:40:03Z","timestamp":1759873203175,"version":"build-2065373602"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Research Plan of SHDC","award":["SHDC2024CRI058"],"award-info":[{"award-number":["SHDC2024CRI058"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81671598","81801601"],"award-info":[{"award-number":["81671598","81801601"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Shanghai","award":["20ZR1451400"],"award-info":[{"award-number":["20ZR1451400"]}]},{"name":"Science and technology commission of Shanghai","award":["20Y11911600"],"award-info":[{"award-number":["20Y11911600"]}]},{"name":"the Shanghai Sailing Program","award":["17YF1417200"],"award-info":[{"award-number":["17YF1417200"]}]},{"name":"Shanghai Wu Mengchao Medical Foundation","award":["JJHXM-2019011"],"award-info":[{"award-number":["JJHXM-2019011"]}]},{"name":"Sixth cycle of key cultivation disciplines of Tongji Hospital Tongji University","award":["ZDPY24-YD-2"],"award-info":[{"award-number":["ZDPY24-YD-2"]}]},{"name":"Clinical research program of Tongji Hospital Tongji University","award":["ITJZD2408, ITJZD1909, ITJQN2001, ITJQN2315"],"award-info":[{"award-number":["ITJZD2408, ITJZD1909, ITJQN2001, ITJQN2315"]}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["22120240361"],"award-info":[{"award-number":["22120240361"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Pujiang Rheumatic Youth Cultivation Program","award":["SPROG2007, SPROG2210, SPROG2306"],"award-info":[{"award-number":["SPROG2007, SPROG2210, SPROG2306"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-025-09101-x","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:36:19Z","timestamp":1759826179000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of VEXAS Syndrome and Chronic Hepatitis B Virus Infection: a Case Report and Literature Review"],"prefix":"10.1007","volume":"68","author":[{"given":"Kailong","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiale","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Shahzad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"9101_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf094","author":"P Garc\u00eda-Escudero","year":"2025","unstructured":"Garc\u00eda-Escudero P, L\u00f3pez-G\u00f3mez M, L\u00f3pez BM, Dorta AG, Frade-Sosa B, Lizarzaburu MS et al (2025) VEXAS syndrome through a rheumatologist\u2019s lens: insights from a Spanish national cohort. Rheumatology (Oxford). https:\/\/doi.org\/10.1093\/rheumatology\/keaf094","journal-title":"Rheumatology (Oxford)"},{"key":"9101_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105700","volume":"91","author":"M-Y Khitri","year":"2024","unstructured":"Khitri M-Y, Hadjadj J, Mekinian A, Jachiet V (2024) VEXAS syndrome: an update. Joint Bone Spine 91:105700","journal-title":"Joint Bone Spine"},{"key":"9101_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1001\/jama.2022.24836","volume":"329","author":"DB Beck","year":"2023","unstructured":"Beck DB, Bodian DL, Shah V, Mirshahi UL, Kim J, Ding Y et al (2023) Estimated prevalence and clinical manifestations of UBA1 variants associated with VEXAS syndrome in a clinical population. JAMA 329:318\u2013324","journal-title":"JAMA"},{"key":"9101_CR4","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1056\/NEJMoa2026834","volume":"383","author":"DB Beck","year":"2020","unstructured":"Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W et al (2020) Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 383:2628\u20132638","journal-title":"N Engl J Med"},{"key":"9101_CR5","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1093\/rheumatology\/keae123","volume":"63","author":"R Echerbault","year":"2024","unstructured":"Echerbault R, Bourguiba R, Georgin-Lavialle S, Lavigne C, Ravaiau C, Lacombe V (2024) Comparing clinical features between males and females with VEXAS syndrome: data from literature analysis of patient reports. Rheumatology (Oxford) 63:2694\u20132700","journal-title":"Rheumatology (Oxford)"},{"key":"9101_CR6","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1056\/NEJMc2102124","volume":"384","author":"J-B Arlet","year":"2021","unstructured":"Arlet J-B, Terrier B, Kosmider O (2021) Mutant UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med 384:2163","journal-title":"N Engl J Med"},{"key":"9101_CR7","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1002\/art.41743","volume":"73","author":"MA Ferrada","year":"2021","unstructured":"Ferrada MA, Sikora KA, Luo Y, Wells KV, Patel B, Groarke EM et al (2021) Somatic mutations in UBA1 define a distinct subset of relapsing polychondritis patients with VEXAS. Arthritis Rheumatol 73:1886\u20131895","journal-title":"Arthritis Rheumatol"},{"key":"9101_CR8","doi-asserted-by":"publisher","first-page":"e402","DOI":"10.1093\/rheumatology\/keab392","volume":"60","author":"T Barba","year":"2021","unstructured":"Barba T, Jamilloux Y, Durel C-A, Bourbon E, Mestrallet F, Sujobert P et al (2021) VEXAS syndrome in a woman. Rheumatology (Oxford) 60:e402\u2013e403","journal-title":"Rheumatology (Oxford)"},{"key":"9101_CR9","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1182\/blood.2021010811","volume":"137","author":"C Gurnari","year":"2021","unstructured":"Gurnari C, Pagliuca S, Durkin L, Terkawi L, Awada H, Kongkiatkamon S et al (2021) Vacuolization of hematopoietic precursors: an enigma with multiple etiologies. Blood 137:3685\u20133689","journal-title":"Blood"},{"key":"9101_CR10","doi-asserted-by":"publisher","first-page":"11618","DOI":"10.3748\/wjg.v20.i33.11618","volume":"20","author":"R-J Pei","year":"2014","unstructured":"Pei R-J, Chen X-W, Lu M-J (2014) Control of hepatitis B virus replication by interferons and toll-like receptor signaling pathways. World J Gastroenterol 20:11618\u201311629","journal-title":"World J Gastroenterol"},{"key":"9101_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.virs.2023.10.007","volume":"38","author":"L Wang","year":"2023","unstructured":"Wang L, Zeng X, Wang Z, Fang L, Liu J (2023) Recent advances in understanding T cell activation and exhaustion during HBV infection. Virol Sin 38:851\u2013859","journal-title":"Virol Sin"},{"key":"9101_CR12","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1093\/ajcp\/aqad186","volume":"161","author":"H Olteanu","year":"2024","unstructured":"Olteanu H, Patnaik M, Koster MJ, Herrick JL, Chen D, He R et al (2024) Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: a single-institution longitudinal study of 111 bone marrow samples from 52 patients. Am J Clin Pathol 161:609\u2013624","journal-title":"Am J Clin Pathol"},{"key":"9101_CR13","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/ajh.27156","volume":"99","author":"MJ Koster","year":"2024","unstructured":"Koster MJ, Lasho TL, Olteanu H, Reichard KK, Mangaonkar A, Warrington KJ et al (2024) VEXAS syndrome: clinical, hematologic features and a practical approach to diagnosis and management. Am J Hematol 99:284\u2013299","journal-title":"Am J Hematol"},{"key":"9101_CR14","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.reuma.2024.05.003","volume":"20","author":"A Mayo-Juanatey","year":"2024","unstructured":"Mayo-Juanatey A, Fern\u00e1ndez-Llavador MJ, Fern\u00e1ndez-Garc\u00e9s MDM, Valls-Pascual E, Alegre-Sancho JJ (2024) VEXAS syndrome: a 2-case series report. Reumatol Clin (Engl Ed) 20:341\u2013344","journal-title":"Reumatol Clin (Engl Ed)"},{"key":"9101_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1354130","volume":"15","author":"E Diral","year":"2024","unstructured":"Diral E, Campochiaro C, Tomelleri A, Bergonzi GM, Pizzano U, Ponzoni M et al (2024) Case report: cytopenias in VEXAS syndrome\u2014a WHO 2022 based approach in a single-center cohort. Front Immunol 15:1354130","journal-title":"Front Immunol"},{"key":"9101_CR16","first-page":"1456","volume":"21","author":"V Baur","year":"2023","unstructured":"Baur V, Stoevesandt J, Hueber A, H\u00fcffmeier U, Kneitz H, Morbach H et al (2023) VEXAS-Syndrom, eine neu beschriebene autoinflammatorische Systemerkrankung mit dermatologischen Manifestationen. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 21:1456\u20131464","journal-title":"JDDG: Journal der Deutschen Dermatologischen Gesellschaft"},{"key":"9101_CR17","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1182\/bloodadvances.2021004976","volume":"5","author":"IE Obiorah","year":"2021","unstructured":"Obiorah IE, Patel BA, Groarke EM, Wang W, Trick M, Ombrello AK et al (2021) Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1. Blood Adv 5:3203\u20133215","journal-title":"Blood Adv"},{"key":"9101_CR18","unstructured":"VEXAS syndrome: a review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation - PubMed [Internet]. [cited 2025 Aug 23]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36788756\/"},{"key":"9101_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-03003-x","author":"S Duan","year":"2024","unstructured":"Duan S, Luo H, Wang Y, Jiang D, Liu J, Li J et al (2024) Dynamic monitoring of UBA1 somatic mutations in patients with relapsing polychondritis. Orphanet J Rare Dis. https:\/\/doi.org\/10.1186\/s13023-023-03003-x","journal-title":"Orphanet J Rare Dis"},{"key":"9101_CR20","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/ijd.16635","volume":"62","author":"AS Hines","year":"2023","unstructured":"Hines AS, Mohandesi NA, Lehman JS, Koster MJ, Cantwell HM, Alavi A et al (2023) Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings. Int J Dermatol 62:938\u2013945","journal-title":"Int J Dermatol"},{"key":"9101_CR21","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1136\/ard-2023-224460","volume":"82","author":"JM Mascaro","year":"2023","unstructured":"Mascaro JM, Rodriguez-Pinto I, Poza G, Mensa-Vilaro A, Fernandez-Martin J, Caminal-Montero L et al (2023) Spanish cohort of VEXAS syndrome: clinical manifestations, outcome of treatments and novel evidences about UBA1 mosaicism. Ann Rheum Dis 82:1594\u20131605","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"9101_CR22","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1001\/jamadermatol.2024.1657","volume":"160","author":"IJ Tan","year":"2024","unstructured":"Tan IJ, Ferrada MA, Ahmad S, Fike A, Quinn KA, Groarke EM et al (2024) Skin manifestations of VEXAS syndrome and associated genotypes. JAMA Dermatol 160(8):822","journal-title":"JAMA Dermatol"},{"key":"9101_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1097\/DAD.0000000000002716","volume":"46","author":"BJ Brumbaugh","year":"2024","unstructured":"Brumbaugh BJ, Laga AC, Pouli D, Fernandez-Figueras MT, Hoang MP (2024) The histopathology of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: report of 12 skin biopsies from 6 patients. Am J Dermatopathol 46:637\u2013647","journal-title":"Am J Dermatopathol"},{"key":"9101_CR24","doi-asserted-by":"publisher","first-page":"4789","DOI":"10.1007\/s00277-024-05863-0","volume":"103","author":"M De Santis","year":"2024","unstructured":"De Santis M, Tonutti A, Motta F, Todisco G, Manes N, Milanesi C et al (2024) Approaches for the diagnosis and treatment of VEXAS syndrome: the importance of clinical suspicion and the use of methotrexate. Ann Hematol 103:4789\u20134791","journal-title":"Ann Hematol"},{"key":"9101_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/bjd.20805","volume":"186","author":"S Georgin-Lavialle","year":"2022","unstructured":"Georgin-Lavialle S, Terrier B, Guedon AF, Heiblig M, Comont T, Lazaro E et al (2022) Further characterization of clinical and laboratory features in VEXAS syndrome: large\u2010scale analysis of a multicentre case series of 116 French patients*. Br J Dermatol 186:564\u2013574","journal-title":"Br J Dermatol"},{"key":"9101_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-024-04688-9","volume":"18","author":"M Berger","year":"2024","unstructured":"Berger M, Schumacher F, Wollsching-Strobel M, Kroppen D, Stanzel SB, Majorski DS et al (2024) A clinical phenotype of VEXAS syndrome with pleural effusion, infiltrates, and systemic inflammation in a 76-year-old patient: a case report. J Med Case Rep 18:392","journal-title":"J Med Case Rep"},{"key":"9101_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2023-258140","volume":"17","author":"T Knab","year":"2024","unstructured":"Knab T, Gaisl T, Steinack C, Kallweit T, Ulrich S, Roeder M (2024) Pulmonary manifestation of VEXAS syndrome. BMJ Case Rep 17:e258140","journal-title":"BMJ Case Rep"},{"key":"9101_CR28","doi-asserted-by":"publisher","first-page":"151","DOI":"10.63032\/EVGB1553","volume":"3","author":"M Puseljic","year":"2024","unstructured":"Puseljic M, Schmid J, Igrec J, Hatzl S, Scholz L, W\u00f6lfler A et al (2024) Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review. ARP Rheumatol 3:151\u2013156","journal-title":"ARP Rheumatol"},{"key":"9101_CR29","doi-asserted-by":"crossref","unstructured":"Fanlo P, Rom\u00e1n ML de S, Fonollosa A, Ilarramendi J, Heras H, Grayson P. Episcleritis and periorbital edema secondary to VEXAS syndrome. Arch Soc Esp Oftalmol (Engl Ed). 2023;98:607\u201310.","DOI":"10.1016\/j.oftale.2023.07.004"},{"key":"9101_CR30","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/WNO.0000000000002270","volume":"45","author":"BD Colman","year":"2025","unstructured":"Colman BD, Smolyansky ED, Parmar HA, Puvanakumar P, Fraser RG, Ramachandran P et al (2025) Orbital inflammatory manifestations in a patient with VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome. J Neuroophthalmol 45:96\u201399","journal-title":"J Neuroophthalmol"},{"key":"9101_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae550","author":"M Sullivan","year":"2025","unstructured":"Sullivan M, Mead-Harvey C, Sartori-Valinotti JC, Kalantari K, Kusne YN, Patnaik M et al (2025) Vasculitis associated with VEXAS syndrome. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keae550","journal-title":"Rheumatology"},{"key":"9101_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.983939","volume":"9","author":"R Watanabe","year":"2022","unstructured":"Watanabe R, Kiji M, Hashimoto M (2022) Vasculitis associated with VEXAS syndrome: a literature review. Front Med Lausanne 9:983939","journal-title":"Front Med Lausanne"},{"key":"9101_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.medcli.2022.06.018","volume":"159","author":"J Hern\u00e1ndez-Rodr\u00edguez","year":"2022","unstructured":"Hern\u00e1ndez-Rodr\u00edguez J, Mensa-Vilar\u00f3 A, Ar\u00f3stegui JI (2022) Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: the VEXAS syndrome. Med Clin (Barc) 159:489\u2013496","journal-title":"Med Clin (Barc)"},{"key":"9101_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead168","volume":"62","author":"H Karadeniz","year":"2023","unstructured":"Karadeniz H, Cerit M, Avano\u011flu G\u00fcler A, Tufan A, Kanthi Y (2023) Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis. Rheumatology (Oxford) 62:e269\u2013e270","journal-title":"Rheumatology (Oxford)"},{"key":"9101_CR35","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000036738","volume":"102","author":"I Tsourveloudis","year":"2023","unstructured":"Tsourveloudis I, Georgiadi EC, Vatalis G, Kotsi P (2023) Case report of a patient with VEXAS syndrome. Medicine (Baltimore) 102:e36738","journal-title":"Medicine (Baltimore)"},{"key":"9101_CR36","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.1111\/1346-8138.16535","volume":"49","author":"Y Matsuki","year":"2022","unstructured":"Matsuki Y, Kawai R, Suyama T, Katagiri K, Kanazawa N, Inaba Y (2022) A case of VEXAS syndrome with myositis possibly associated with macrophage activation syndrome. J Dermatol 49:e441\u2013e443","journal-title":"J Dermatol"},{"key":"9101_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1377768","volume":"11","author":"M Zisapel","year":"2024","unstructured":"Zisapel M, Seyman E, Molad J, Hallevi H, Mauda-Havakuk M, Jonas-Kimchi T et al (2024) Case report: cerebral sinus vein thrombosis in VEXAS syndrome. Front Med Lausanne 11:1377768","journal-title":"Front Med Lausanne"},{"key":"9101_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-261179","volume":"17","author":"J Burgei","year":"2024","unstructured":"Burgei J, Alsheimer KM, Lantry J, Hehn B (2024) Mediastinal lymphadenopathy due to VEXAS syndrome. BMJ Case Rep 17:e261179","journal-title":"BMJ Case Rep"},{"key":"9101_CR39","first-page":"810","volume":"64","author":"A Ripke","year":"2023","unstructured":"Ripke A, M\u00fcnchau A, von Bubnoff N, Jendrek S, Kopelke S, K\u00fcmpers C et al (2023) B symptoms in unexplained mediastinal lymphadenopathy: case report of a 72-year-old male patient with VEXAS syndrome. Inn Med (Heidelb) 64:810\u2013814","journal-title":"Inn Med (Heidelb)"},{"key":"9101_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17655","author":"P Moreira-Gomes","year":"2025","unstructured":"Moreira-Gomes P, Costa R, Granja B, Rosa G, Matos P, Costa C et al (2025) VEXAS syndrome: an unusual dermatological presentation with histiocytic infiltration. Int J Dermatol. https:\/\/doi.org\/10.1111\/ijd.17655","journal-title":"Int J Dermatol"},{"key":"9101_CR41","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1182\/blood.2022016985","volume":"140","author":"MA Ferrada","year":"2022","unstructured":"Ferrada MA, Savic S, Cardona DO, Collins JC, Alessi H, Gutierrez-Rodrigues F et al (2022) Translation of cytoplasmic UBA1 contributes to VEXAS syndrome pathogenesis. Blood 140:1496\u20131506","journal-title":"Blood"},{"key":"9101_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/1744666X.2023.2157262","volume":"19","author":"A Al-Hakim","year":"2023","unstructured":"Al-Hakim A, Savic S (2023) An update on VEXAS syndrome. Expert Rev Clin Immunol 19:203\u2013215","journal-title":"Expert Rev Clin Immunol"},{"key":"9101_CR43","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ajcp\/aqae017","volume":"162","author":"A Hagiya","year":"2024","unstructured":"Hagiya A, Siddiqi IN, Wang E, Lu CM (2024) How i diagnose and manage VEXAS syndrome. Am J Clin Pathol 162:28\u201340","journal-title":"Am J Clin Pathol"},{"key":"9101_CR44","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41584-022-00778-4","volume":"18","author":"DB Beck","year":"2022","unstructured":"Beck DB, Werner A, Kastner DL, Aksentijevich I (2022) Disorders of ubiquitylation: unchained inflammation. Nat Rev Rheumatol 18:435\u2013447","journal-title":"Nat Rev Rheumatol"},{"key":"9101_CR45","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s44318-024-00046-z","volume":"43","author":"JC Collins","year":"2024","unstructured":"Collins JC, Magaziner SJ, English M, Hassan B, Chen X, Balanda N et al (2024) Shared and distinct mechanisms of UBA1 inactivation across different diseases. EMBO J 43:1919\u20131946","journal-title":"EMBO J"},{"key":"9101_CR46","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1111\/imj.16479","volume":"54","author":"L Kablar","year":"2024","unstructured":"Kablar L, Corkill M, Menezes CN (2024) VEXAS syndrome: a novel autoinflammatory disorder in an elderly male patient. Intern Med J 54:1424\u20131425","journal-title":"Intern Med J"},{"key":"9101_CR47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3389\/fimmu.2017.00399","volume":"8","author":"I Aksentijevich","year":"2017","unstructured":"Aksentijevich I, Zhou Q (2017) NF-\u03baB pathway in autoinflammatory diseases: dysregulation of protein modifications by ubiquitin defines a new category of autoinflammatory diseases. Front Immunol 8:399","journal-title":"Front Immunol"},{"key":"9101_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.716469","volume":"12","author":"L Barnabei","year":"2021","unstructured":"Barnabei L, Laplantine E, Mbongo W, Rieux-Laucat F, Weil R (2021) NF-\u03baB: at the borders of autoimmunity and inflammation. Front Immunol 12:716469","journal-title":"Front Immunol"},{"key":"9101_CR49","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1080\/15548627.2019.1656957","volume":"16","author":"K Niu","year":"2020","unstructured":"Niu K, Fang H, Chen Z, Zhu Y, Tan Q, Wei D et al (2020) USP33 deubiquitinates PRKN\/parkin and antagonizes its role in mitophagy. Autophagy 16:724\u2013734","journal-title":"Autophagy"},{"key":"9101_CR50","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.1182\/blood.2020010177","volume":"137","author":"E Bourbon","year":"2021","unstructured":"Bourbon E, Heiblig M, Gerfaud Valentin M, Barba T, Durel C-A, Lega JC et al (2021) Therapeutic options in VEXAS syndrome: insights from a retrospective series. Blood 137:3682\u20133684","journal-title":"Blood"},{"key":"9101_CR51","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nri3062","volume":"11","author":"KY King","year":"2011","unstructured":"King KY, Goodell MA (2011) Inflammatory modulation of HSCs: viewing the HSC as a foundation for the immune response. Nat Rev Immunol 11:685\u2013692","journal-title":"Nat Rev Immunol"},{"key":"9101_CR52","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1182\/blood-2005-05-1884","volume":"107","author":"W Zeng","year":"2006","unstructured":"Zeng W, Miyazato A, Chen G, Kajigaya S, Young NS, Maciejewski JP (2006) Interferon-gamma-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles. Blood 107:167\u2013175","journal-title":"Blood"},{"key":"9101_CR53","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/s41556-022-01053-0","volume":"25","author":"CA Mitchell","year":"2023","unstructured":"Mitchell CA, Verovskaya EV, Calero-Nieto FJ, Olson OC, Swann JW, Wang X et al (2023) Stromal niche inflammation mediated by IL-1 signalling is a targetable driver of haematopoietic ageing. Nat Cell Biol 25:30\u201341","journal-title":"Nat Cell Biol"},{"key":"9101_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106181","volume":"178","author":"Q Zhou","year":"2022","unstructured":"Zhou Q, Zhang Q, Wang K, Huang T, Deng S, Wang Y et al (2022) Anti-rheumatic drug-induced hepatitis B virus reactivation and preventive strategies for hepatocellular carcinoma. Pharmacol Res 178:106181","journal-title":"Pharmacol Res"},{"key":"9101_CR55","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40537-x","volume":"14","author":"W Yan","year":"2023","unstructured":"Yan W, Zhong Y, Hu X, Xu T, Zhang Y, Kales S et al (2023) Auranofin targets UBA1 and enhances UBA1 activity by facilitating ubiquitin trans-thioesterification to E2 ubiquitin-conjugating enzymes. Nat Commun 14:4798","journal-title":"Nat Commun"},{"key":"9101_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","volume":"133","author":"G Weiss","year":"2019","unstructured":"Weiss G, Ganz T, Goodnough LT (2019) Anemia of inflammation. Blood 133:40\u201350","journal-title":"Blood"},{"key":"9101_CR57","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1007\/s12185-023-03598-8","volume":"118","author":"H Kunimoto","year":"2023","unstructured":"Kunimoto H, Miura A, Maeda A, Tsuchida N, Uchiyama Y, Kunishita Y et al (2023) Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome. Int J Hematol 118:494\u2013502","journal-title":"Int J Hematol"},{"key":"9101_CR58","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/art.42101","volume":"74","author":"C Campochiaro","year":"2022","unstructured":"Campochiaro C, Tomelleri A, Cavalli G, De Luca G, Grassini G, Cangi MG et al (2022) Successful use of cyclosporin A and interleukin-1 blocker combination therapy in VEXAS syndrome: a single-center case series. Arthritis Rheumatol 74:1302\u20131303","journal-title":"Arthritis Rheumatol"},{"key":"9101_CR59","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1182\/blood-2011-09-377044","volume":"119","author":"OC Goodyear","year":"2012","unstructured":"Goodyear OC, Dennis M, Jilani NY, Loke J, Siddique S, Ryan G et al (2012) Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML). Blood 119:3361\u20133369","journal-title":"Blood"},{"key":"9101_CR60","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.leukres.2016.02.005","volume":"43","author":"J-B Fraison","year":"2016","unstructured":"Fraison J-B, Mekinian A, Grignano E, Kahn J-E, Arlet J-B, Decaux O et al (2016) Efficacy of azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res 43:13\u201317","journal-title":"Leuk Res"},{"key":"9101_CR61","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.3324\/haematol.2024.285519","volume":"109","author":"R Trikha","year":"2024","unstructured":"Trikha R, Kong KL, Galloway J, Basu TN, Quek L, Wilson J et al (2024) De-escalation of corticosteroids and clonal remission in UBA1 mutation-driven VEXAS syndrome with 5-azacytidine. Haematologica 109:3431\u20133434","journal-title":"Haematologica"},{"key":"9101_CR62","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1007\/s00277-024-06072-5","volume":"103","author":"T Porges","year":"2024","unstructured":"Porges T, Rosenberg E, Wolach O, Sagy I, Sherf Y, Levi I (2024) Case report: VEXAS syndrome with excellent response to treatment with azacitidine. Ann Hematol 103:5935\u20135939","journal-title":"Ann Hematol"},{"key":"9101_CR63","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00277-023-05611-w","volume":"103","author":"K Sockel","year":"2024","unstructured":"Sockel K, G\u00f6tze K, Ganster C, Bill M, Georgi J-A, Balaian E et al (2024) VEXAS syndrome: complete molecular remission after hypomethylating therapy. Ann Hematol 103:993\u2013997","journal-title":"Ann Hematol"},{"key":"9101_CR64","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s10067-022-06338-1","volume":"41","author":"CA Guerrero-Berm\u00fadez","year":"2022","unstructured":"Guerrero-Berm\u00fadez CA, Cardona-Cardona AF, Ariza-Parra EJ, Arostegui JI, Mensa-Vilaro A, Yague J et al (2022) Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome (VEXAS syndrome) with prominent supraglottic larynx involvement: a case-based review. Clin Rheumatol 41:3565\u20133572","journal-title":"Clin Rheumatol"},{"key":"9101_CR65","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/15353702231165030","volume":"248","author":"S Bindoli","year":"2023","unstructured":"Bindoli S, Baggio C, Doria A, Bertoldo E, Sfriso P (2023) JAK inhibitors for the treatment of VEXAS syndrome. Exp Biol Med (Maywood) 248:394\u2013398","journal-title":"Exp Biol Med (Maywood)"},{"key":"9101_CR66","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1136\/ard-2024-225640","volume":"83","author":"J Hadjadj","year":"2024","unstructured":"Hadjadj J, Nguyen Y, Mouloudj D, Bourguiba R, Heiblig M, Aloui H et al (2024) Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX. Ann Rheum Dis 83:1358\u20131367","journal-title":"Ann Rheum Dis"},{"key":"9101_CR67","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jhin.2022.04.007","volume":"126","author":"B Minihan","year":"2022","unstructured":"Minihan B, McAuliffe E, Powell J, Wong SL, Wilkie K, Murphy C et al (2022) Association between tocilizumab treatment of hyperinflammatory patients with COVID-19 in a critical care setting and elevated incidence of hospital-acquired bacterial and invasive fungal infections. J Hosp Infect 126:29\u201336","journal-title":"J Hosp Infect"},{"key":"9101_CR68","first-page":"1767","volume":"386","author":"F D\u2019Amico","year":"2022","unstructured":"D\u2019Amico F, Peyrin-Biroulet L, Danese S (2022) Cardiovascular and cancer risk with tofacitinib in rheumatoid arthritis. N Engl J Med 386:1767\u20131768","journal-title":"N Engl J Med"},{"key":"9101_CR69","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1136\/annrheumdis-2016-209773","volume":"76","author":"A Strangfeld","year":"2017","unstructured":"Strangfeld A, Richter A, Siegmund B, Herzer P, Rockwitz K, Demary W et al (2017) Risk for lower intestinal perforations in patients with rheumatoid arthritis treated with tocilizumab in comparison to treatment with other biologic or conventional synthetic DMARDs. Ann Rheum Dis 76:504\u2013510","journal-title":"Ann Rheum Dis"},{"key":"9101_CR70","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jaci.2021.05.014","volume":"149","author":"CI van der Made","year":"2022","unstructured":"van der Made CI, Potjewijd J, Hoogstins A, Willems HPJ, Kwakernaak AJ, de Sevaux RGL et al (2022) Adult-onset autoinflammation caused by somatic mutations in UBA1: a Dutch case series of patients with VEXAS. J Allergy Clin Immunol 149:432-439.e4","journal-title":"J Allergy Clin Immunol"},{"key":"9101_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1383730","volume":"14","author":"P Bellman","year":"2024","unstructured":"Bellman P, Gonzalez-Lugo JD, Shahzad M, Amin MK, Khalid MF, Suleman N et al (2024) Successful treatment with fludarabine and cyclophosphamide in a VEXAS syndrome patient with associated myelodysplastic syndrome: a case report and systematic review. Front Oncol 14:1383730","journal-title":"Front Oncol"},{"key":"9101_CR72","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042261","volume":"25","author":"A Cardoneanu","year":"2024","unstructured":"Cardoneanu A, Rezus II, Burlui AM, Richter P, Bratoiu I, Mihai IR et al (2024) Autoimmunity and autoinflammation: relapsing polychondritis and VEXAS syndrome challenge. Int J Mol Sci 25:2261","journal-title":"Int J Mol Sci"},{"key":"9101_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-44811-4","volume":"15","author":"O Kosmider","year":"2024","unstructured":"Kosmider O, Poss\u00e9m\u00e9 C, Templ\u00e9 M, Corneau A, Carbone F, Duroyon E et al (2024) VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation. Nat Commun 15:910","journal-title":"Nat Commun"},{"key":"9101_CR74","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X20912646","volume":"12","author":"C Koutsianas","year":"2020","unstructured":"Koutsianas C, Thomas K, Vassilopoulos D (2020) Reactivation of hepatitis B virus infection in rheumatic diseases: risk and management considerations. Ther Adv Musculoskelet Dis 12:1759720X20912646","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"9101_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/14397595.2013.852834","volume":"24","author":"M Harigai","year":"2014","unstructured":"Harigai M, Mochida S, Mimura T, Koike T, Miyasaka N (2014) A proposal for management of rheumatic disease patients with hepatitis B virus infection receiving immunosuppressive therapy. Mod Rheumatol 24:1\u20137","journal-title":"Mod Rheumatol"},{"key":"9101_CR76","doi-asserted-by":"crossref","unstructured":"Dolman GE, Kennedy PTF. Hepatitis B reactivation: reducing the risk in patients with inflammatory bowel disease. Gut [Internet]. 2020 [cited 2025 May 20];69:2053\u20134. Available from: https:\/\/gut.bmj.com\/content\/69\/11\/2053","DOI":"10.1136\/gutjnl-2019-319480"},{"key":"9101_CR77","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179116","volume":"22","author":"M-H Chen","year":"2021","unstructured":"Chen M-H, Wu C-S, Chen M-H, Tsai C-Y, Lee F-Y, Huang Y-H (2021) High risk of viral reactivation in hepatitis B patients with systemic lupus erythematosus. Int J Mol Sci 22:9116","journal-title":"Int J Mol Sci"},{"key":"9101_CR78","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1080\/14397595.2017.1419842","volume":"28","author":"T Matsuzaki","year":"2018","unstructured":"Matsuzaki T, Eguchi K, Nagao N, Tsuji S, Aramaki T, Terada K et al (2018) Hepatitis B virus reactivation in patients with rheumatoid arthritis: a single-center study. Mod Rheumatol 28:808\u2013813","journal-title":"Mod Rheumatol"},{"key":"9101_CR79","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1177\/0961203317711009","volume":"27","author":"WT Lin","year":"2018","unstructured":"Lin WT, Chen YM, Chen DY, Lan JL, Chang CS, Yeh HZ et al (2018) Increased risk of hepatitis B virus reactivation in systemic lupus erythematosus patients receiving immunosuppressants: a retrospective cohort study. Lupus 27:66\u201375","journal-title":"Lupus"},{"key":"9101_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s00296-009-1202-2","volume":"31","author":"A Pyrpasopoulou","year":"2011","unstructured":"Pyrpasopoulou A, Douma S, Vassiliadis T, Chatzimichailidou S, Triantafyllou A, Aslanidis S (2011) Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis. Rheumatol Int 31:403\u2013404","journal-title":"Rheumatol Int"},{"key":"9101_CR81","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1053\/j.seminhematol.2021.10.002","volume":"58","author":"MJ Koster","year":"2021","unstructured":"Koster MJ, Warrington KJ (2021) VEXAS within the spectrum of rheumatologic disease. Semin Hematol 58:218\u2013225","journal-title":"Semin Hematol"},{"key":"9101_CR82","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1007\/s00296-023-05513-0","volume":"44","author":"K Kouranloo","year":"2024","unstructured":"Kouranloo K, Dey M, Almutawa J, Myall N, Nune A (2024) Clinical characteristics, disease trajectories and management of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome: a systematic review. Rheumatol Int 44:1219\u20131232","journal-title":"Rheumatol Int"},{"key":"9101_CR83","doi-asserted-by":"crossref","unstructured":"Lamas A, Pinto F, Oliveira DG, Oliveira ME, Gon\u00e7alves AR, Santos F, et al. AB0040 Vexas syndrome: clinical characteristics, treatment and outcome experience from a single centre cohort. Annals of the Rheumatic Diseases [Internet]. 2024 [cited 2025 May 8];83:1246\u20137. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S0003496724167271","DOI":"10.1136\/annrheumdis-2024-eular.5937"},{"key":"9101_CR84","unstructured":"POS1579 Vexas syndrome in a patient with biopsy positive GCA and imaging proven large vessel vasculitis treated with tocilizumab | Annals of the Rheumatic Diseases [Internet]. [cited 2025 May 8]. Available from: https:\/\/ard.bmj.com\/content\/82\/Suppl_1\/1166.3"},{"key":"9101_CR85","unstructured":"Clinical manifestations are evolving and progressive in patients with Vexas syndrome | Blood | American Society of Hematology [Internet]. [cited 2025 May 8]. Available from: https:\/\/ashpublications.org\/blood\/article\/142\/Supplement%201\/703\/500185\/Clinical-Manifestations-Are-Evolving-and"},{"key":"9101_CR86","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/ajh.27169","volume":"99","author":"C Gurnari","year":"2024","unstructured":"Gurnari C, Pascale MR, Vitale A, Diral E, Tomelleri A, Galossi E et al (2024) Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort. Am J Hematol 99:254\u2013262","journal-title":"Am J Hematol"},{"key":"9101_CR87","unstructured":"Adult-onset autoinflammation caused by somatic mutations in UBA1: A Dutch case series of patients with VEXAS - PubMed [Internet]. [cited 2025 May 8]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34048852\/"},{"key":"9101_CR88","unstructured":"Clinical heterogeneity of the VEXAS syndrome: a case series. PubMed [Internet]. [cited 2025 May 8]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34489099\/"},{"key":"9101_CR89","unstructured":"Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients - PubMed [Internet]. [cited 2025 May 8]. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34632574\/"},{"key":"9101_CR90","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.1182\/blood.2020010286","volume":"137","author":"JA Poulter","year":"2021","unstructured":"Poulter JA, Collins JC, Cargo C, De Tute RM, Evans P, Ospina Cardona D et al (2021) Novel somatic mutations in UBA1 as a cause of VEXAS syndrome. Blood 137:3676\u20133681","journal-title":"Blood"},{"key":"9101_CR91","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/art.42471","volume":"75","author":"B Stiburkova","year":"2023","unstructured":"Stiburkova B, Pavelcova K, Belickova M, Magaziner SJ, Collins JC, Werner A et al (2023) Novel Somatic <scp>UBA1<\/scp> Variant in a Patient With <scp>VEXAS<\/scp> Syndrome. Arthritis Rheumatol 75:1285\u20131290","journal-title":"Arthritis Rheumatol"},{"key":"9101_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead536","volume":"63","author":"H Oka","year":"2024","unstructured":"Oka H, Sumitomo S, Nishikubo M, Yamashita D, Maruoka H, Shiroishi Y et al (2024) VEXAS syndrome with granulomatosis with polyangiitis manifestation: retained in remission using methotrexate and infliximab. Rheumatology (Oxford) 63:e110\u2013e112","journal-title":"Rheumatology (Oxford)"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-025-09101-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-025-09101-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T21:10:54Z","timestamp":1759871454000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-025-09101-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9101"],"URL":"https:\/\/doi.org\/10.1007\/s12016-025-09101-x","relation":{},"ISSN":["1559-0267"],"issn-type":[{"type":"electronic","value":"1559-0267"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"24 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The following report was written in accordance with local ethical guidelines, and full informed consent was obtained from the patient, in line with submitting guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"The patient\u2019s written consent for publication was obtained for this report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}